Key Highlights:
- Fermenta Biotech’s equity shares have been listed and admitted to trading on the National Stock Exchange (NSE) under the symbol FERMENTA, marking the company’s expansion to a dual-exchange listing.
- The listing enhances the accessibility and liquidity of Fermenta’s shares while broadening its reach to a larger investor base, complementing its existing listing on the BSE.
- Fermenta Biotech, a global manufacturer of Vitamin D3 and nutritional ingredients, expects the NSE listing to strengthen its capital market presence and improve shareholder value over the long term.
Implications:
By adding the NSE to its existing BSE listing, Fermenta can attract more institutional and retail participation, which may support tighter spreads, better price discovery, and easier access to capital for future expansions in Vitamin D3, green chemistry, and nutritional ingredients. Combined with recent momentum around its plant-based VITADEE Green and FSSAI approval, the move can reinforce its narrative as a differentiated, non-China-dependent supplier in a growing global vitamin and nutraceutical market.
Source: NSE
